The neurobiology of attention deficit/hyperactivity disorder.

ADHD is a brain based disorder with structural and functional abnormalities in widespread but specific areas of the brain. The most significant and consistent structural imaging findings include smaller total brain volumes, and reduced volumes in the right frontal lobe, right parietal cortex, caudate nucleus, cerebellar hemispheres, and posterior-inferior lobules of the cerebellar vermis. ADHD involves hypofunction of catecholaminergic circuits, particularly those that project to the prefrontal cortex. A minimum of 18 genes have been reported to be associated with the disorder; among them the DRD4 7-repeat allele has been found associated with a thinner prefrontal and posterior parietal cortex. Epigenetic factors acting during critical periods of prenatal and postnatal development may interact with genetic determinants. Methylphenidate, as well as the catecholaminergic nonstimulant atomoxetine, are effective in improving ADHD symptoms.

[1]  V. Harpin,et al.  The effect of ADHD on the life of an individual, their family, and community from preschool to adult life , 2005, Archives of Disease in Childhood.

[2]  M. Denckla,et al.  Anomalies of motor development in hyperactive boys , 1978, Annals of neurology.

[3]  P. Curatolo,et al.  Attention and executive functions profile in drug naive ADHD subtypes , 2007, Brain and Development.

[4]  S. Faraone,et al.  Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. , 2002, Journal of the American Academy of Child and Adolescent Psychiatry.

[5]  P. Curatolo.  The neurology of attention deficit/hyperactivity disorder , 2005, Brain and Development.

[6]  C. Hultman,et al.  Birth weight and attention-deficit/hyperactivity symptoms in childhood and early adolescence: a prospective Swedish twin study. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.

[7]  R. Barkley.  Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. , 1997, Psychological bulletin.

[8]  J. Rodgers,et al.  Causal inferences regarding prenatal alcohol exposure and childhood externalizing problems. , 2007, Archives of general psychiatry.

[9]  E. Bullmore,et al.  Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI. , 1999, The American journal of psychiatry.

[10]  Alan C. Evans,et al.  Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. , 2002, JAMA.

[11]  M. Järvelin,et al.  Smoking during pregnancy and hyperactivity-inattention in the offspring--comparing results from three Nordic cohorts. , 2009, International journal of epidemiology.

[12]  B. J. Casey,et al.  Differential patterns of striatal activation in young children with and without ADHD , 2003, Biological Psychiatry.

[13]  W. Iacono,et al.  Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse. , 2007, Archives of general psychiatry.

[14]  Paul A. Newhouse,et al.  Central nicotinic cholinergic systems: A role in the cognitive dysfunction in Attention-Deficit/Hyperactivity Disorder? , 2006, Behavioural Brain Research.

[15]  E. D. Bond,et al.  POST-ENCEPHALITIC BEHAVIOR DISORDERS , 1935 .

[16]  B. Hoza.  Peer functioning in children with ADHD. , 2007, Ambulatory pediatrics : the official journal of the Ambulatory Pediatric Association.

[17]  Yu-Shin Ding,et al.  Imaging the Effects of Methylphenidate on Brain Dopamine: New Model on Its Therapeutic Actions for Attention-Deficit/Hyperactivity Disorder , 2005, Biological Psychiatry.

[18]  y Bradle,et al.  BEHAVIOR OF CHILDREN RECEIVING BENZEDRINE , 1938 .

[19]  Joan M. Coffin,et al.  Impaired Cerebellar Learning in Children with Prenatal Alcohol Exposure: A Comparative Study of Eyeblink Conditioning in Children with ADHD and Dyslexia , 2005, Cortex.

[20]  T. Spencer,et al.  Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders , 2005, Neurology.

[21]  M. Denckla.  ADHD: topic update , 2003, Brain and Development.

[22]  R. Benecke,et al.  Restoration of Disturbed Intracortical Motor Inhibition and Facilitation in Attention Deficit Hyperactivity Disorder Children by Methylphenidate , 2007, Biological Psychiatry.

[23]  G H Glover,et al.  Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[24]  James J. Pekar,et al.  Functional Magnetic Resonance Imaging Evidence for Abnormalities in Response Selection in Attention Deficit Hyperactivity Disorder: Differences in Activation Associated with Response Inhibition but Not Habitual Motor Response , 2008, Journal of Cognitive Neuroscience.

[25]  Joseph Biederman,et al.  Attention-Deficit/Hyperactivity Disorder: A Selective Overview , 2005, Biological Psychiatry.

[26]  Larry J. Seidman,et al.  Functional MRI in attention-deficit hyperactivity disorder: Evidence for hypofrontality , 2005, Brain and Development.

[27]  J L Bradshaw,et al.  Right parietal dysfunction in children with attention deficit hyperactivity disorder, combined type: a functional MRI study , 2007, Molecular Psychiatry.

[28]  F. Castellanos,et al.  Characterizing cognition in ADHD: beyond executive dysfunction , 2006, Trends in Cognitive Sciences.

[29]  Nitin Gogtay,et al.  Brain Neuroplasticity in Healthy, Hyperactive and Psychotic Children: Insights from Neuroimaging , 2008, Neuropsychopharmacology.

[30]  A L Reiss,et al.  Specification of the neurobehavioral phenotype in males with fragile X syndrome. , 1995, Pediatrics.

[31]  Martin H. Schmidt,et al.  Interaction of dopamine transporter genotype with prenatal smoke exposure on ADHD symptoms. , 2008, The Journal of pediatrics.

[32]  Jie Zhang,et al.  Dopamine transporter genotype influences the physiological response to medication in ADHD. , 2006, Brain : a journal of neurology.

[33]  M. Denckla,et al.  The Association of Neurofibromatosis Type 1 and Attention Deficit Hyperactivity Disorder , 2000, Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence.

[34]  Alan C. Evans,et al.  Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation , 2007, Proceedings of the National Academy of Sciences.

[35]  M. Martres,et al.  Functional alterations of nicotinic neurotransmission in dopamine transporter knock-out mice , 2007, Neuropharmacology.

[36]  G. Fink,et al.  Long-term effects of methylphenidate on neural networks associated with executive attention in children with ADHD: results from a longitudinal functional MRI study. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.

[37]  R. Todd,et al.  Prenatal Smoking Exposure and Dopaminergic Genotypes Interact to Cause a Severe ADHD Subtype , 2007, Biological Psychiatry.

[38]  J. Stockman.  Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blinded, placebo-controlled trial , 2009 .

[39]  B. Sen,et al.  Maternal prenatal substance use and behavior problems among children in the U.S. , 2007, The journal of mental health policy and economics.

[40]  J. Biederman,et al.  Psychopharmacological interventions. , 2008, Child and adolescent psychiatric clinics of North America.

[41]  Darin D Dougherty,et al.  PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate. , 2006, The American journal of psychiatry.

[42]  J. Halperin,et al.  The neurobiology of attention-deficit hyperactivity disorder. , 2000, Frontiers in bioscience : a journal and virtual library.

[43]  Philip Shaw,et al.  Cerebellar development and clinical outcome in attention deficit hyperactivity disorder. , 2007, The American journal of psychiatry.

[44]  K. Matthews,et al.  The Neuropsychological Effects of Chronic Methylphenidate on Drug-Naive Boys with Attention-Deficit/Hyperactivity Disorder , 2007, Biological Psychiatry.

[45]  B. Pennington,et al.  Validity of the Executive Function Theory of Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review , 2005, Biological Psychiatry.

[46]  M. Järvelin,et al.  Do inattention and hyperactivity symptoms equal scholastic impairment? evidence from three European cohorts , 2007, BMC public health.

[47]  S. Rauch,et al.  Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the counting stroop , 1999, Biological Psychiatry.

[48]  Edmund J. S. Sonuga-Barke,et al.  Causal Models of Attention-Deficit/Hyperactivity Disorder: From Common Simple Deficits to Multiple Developmental Pathways , 2005, Biological Psychiatry.

[49]  J. Nigg,et al.  An integrative theory of attention-deficit/ hyperactivity disorder based on the cognitive and affective neurosciences , 2005, Development and Psychopathology.

[50]  H. Geurts,et al.  The top and the bottom of ADHD: a neuropsychological perspective , 2003, Neuroscience & Biobehavioral Reviews.

[51]  Ali A. Bonab,et al.  In Vivo Neuroreceptor Imaging in Attention-Deficit/Hyperactivity Disorder: A Focus on The Dopamine Transporter , 2005, Biological Psychiatry.

[52]  Abraham Weizman,et al.  Association of the low-activity COMT 158Met allele with ADHD and OCD in subjects with velocardiofacial syndrome. , 2007, The international journal of neuropsychopharmacology.

[53]  Elizabeth B. Owens,et al.  Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

[54]  P. Lichtenstein,et al.  Long-term relationships between symptoms of Attention Deficit Hyperactivity Disorder and self-esteem in a prospective longitudinal study of twins. , 2006 .

[55]  Keith M. Shafritz,et al.  The effects of methylphenidate on neural systems of attention in attention deficit hyperactivity disorder. , 2004, The American journal of psychiatry.

[56]  S. Pliszka.  The Neuropsychopharmacology of Attention-Deficit/Hyperactivity Disorder , 2005, Biological Psychiatry.

[57]  C. Francks,et al.  Attention Deficit Hyperactivity Disorder: Fine Mapping Supports Linkage to 5p13, 6q12, 16p13, and 17p11 , 2022 .

[58]  Florence Levy,et al.  Behavioral and Brain Functions , 2007 .

[59]  P. Asherson,et al.  Attention–Deficit Hyperactivity Disorder in the post–genomic era , 2004, European child & adolescent psychiatry.

[60]  Alan C. Evans,et al.  Longitudinal mapping of cortical thickness and clinical outcome in children and adolescents with attention-deficit/hyperactivity disorder. , 2006, Archives of general psychiatry.

[61]  R. Delfino,et al.  The ADHD spectrum and everyday life: experience sampling of adolescent moods, activities, smoking, and drinking. , 2002, Child development.

[62]  S. Faraone,et al.  Meta-Analysis of Structural Imaging Findings in Attention-Deficit/Hyperactivity Disorder , 2007, Biological Psychiatry.

[63]  S. Faraone,et al.  The nature and heritability of attention-deficit/hyperactivity disorder. , 2001, Child and adolescent psychiatric clinics of North America.

[64]  J. McGough,et al.  Maternal smoking and hyperactivity in 8-year-old children. , 2003, Journal of the American Academy of Child and Adolescent Psychiatry.

[65]  H. Feldman,et al.  Academic and educational outcomes of children with ADHD. , 2007, Journal of pediatric psychology.

[66]  B. Pasamanick,et al.  Syndrome of minimal cerebral damage in infancy. , 1959, Journal of the American Medical Association.

[67]  H. Heinrich,et al.  Deficient intracortical inhibition in drug-naive children with attention-deficit hyperactivity disorder is enhanced by methylphenidate , 2000, Neuroscience Letters.

[68]  S. Faraone,et al.  Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in children , 1996 .

[69]  Nirbhay N. Singh,et al.  Psychopharmacological Intervention I , 1990 .

[70]  P. Curatolo,et al.  Tuberous sclerosis complex: a review of neurological aspects. , 2002, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[71]  J Sergeant,et al.  The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes , 2006, Molecular Psychiatry.

[72]  Nikos Makris,et al.  Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task. , 2008, Archives of general psychiatry.